Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. November 2010 09:31 ET | Quelle: SIGA Technologies Inc.

SIGA Comments on U.S. Government Survey on Smallpox Antiviral Acquisition

NEW YORK, Nov. 18, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, noted today that...
07. November 2010 18:22 ET | Quelle: SIGA Technologies Inc.

SIGA to Appeal Adverse Small Business Size Determination

NEW YORK, Nov. 7, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, announced today...
02. November 2010 16:05 ET | Quelle: SIGA Technologies Inc.

SIGA Technologies Reports Financial Results for the Third Quarter of 2010

NEW YORK, Nov. 2, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today reported its...
29. Oktober 2010 12:30 ET | Quelle: SIGA Technologies Inc.

SIGA to Discuss Third Quarter Results of Operations on November 2, 2010

NEW YORK, Oct. 29, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, announced today...
13. Oktober 2010 08:30 ET | Quelle: SIGA Technologies Inc.

SIGA Selected for the Procurement of Smallpox Antiviral Drug for the Strategic National Stockpile and Responds to Small Business Size Protest

NEW YORK, Oct. 13, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, announced today...
05. August 2010 16:05 ET | Quelle: SIGA Technologies Inc.

SIGA Technologies Reports Financial Results for the Second Quarter and First Half of 2010

NEW YORK, Aug. 5, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced its...
02. August 2010 08:30 ET | Quelle: SIGA Technologies Inc.

SIGA to Discuss Second Quarter Results of Operations on August 5, 2010

NEW YORK, Aug. 2, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, announced today that...
23. Juni 2010 08:30 ET | Quelle: SIGA Technologies Inc.

SIGA Completes Fourth Successful Human Safety Clinical Trial

NEW YORK, June 23, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, announced today...
21. Juni 2010 08:30 ET | Quelle: SIGA Technologies Inc.

Andy Stern Joins SIGA's Board of Directors

NEW YORK, June 21, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, announced today...
12. Mai 2010 14:54 ET | Quelle: SIGA Technologies Inc.

SIGA CEO Dr. Eric Rose Addresses Congressional Appropriations Subcommittee on Behalf of the Alliance for Biosecurity

NEW YORK, May 12, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of drugs to fight biowarfare pathogens, today announced that its Chief...

Vorherige Seite